Patent details

Basic Information

Publication number:

EP2785702

PCT Application Number:

EP2012073783

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127917649

PCT Publication Number:

WO2013079501

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTALLINE DAPAGLIFLOZIN HYDRATE

French Title of Invention:

HYDRATE DE DAPAGLIFLOZINE CRISTALLINE

German Title of Invention:

KRISTALLINES DAPAGLIFLOZINHYDRAT

SPC Number:

Dates

Filing date:

28/11/2012

Grant date:

22/01/2020

EP Publication Date:

08/10/2014

PCT Publication Date:

06/06/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/01/2020

EP B1 Publication Date:

22/01/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/11/2020

Expiration date:

28/11/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/01/2020

 

 

Name:

Sandoz AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

REICHEN-BÄCHER, Katharina

Address:

Switzerland (CH)

2

Name:

BLATTER, Fritz

Address:

Switzerland (CH)

Priority

Priority Number:

11190866

Priority Date:

28/11/2011

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 31/351; A61P 3/10; C07D 309/10;

Publication

European Patent Bulletin

1

Issue number:

202004

Publication date:

22/01/2020

Description:

Grant (B1)

2

Issue number:

202049

Publication date:

02/12/2020

Description:

Opposition procedure started

3

Issue number:

202422

Publication date:

29/05/2024

Description:

Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages